Lead fracture management in implanted cardiac devices

Lead fracture is an uncommon but potentially dangerous failure of a cardiovascular implantable electronic device (CIED). A damaged pacemaker or implantable cardioverter-defibrillator (ICD) conductor can interrupt bradycardia support, prevent effective sensing, or trigger inappropriate shocks. The clinical picture ranges from an incidental change on remote monitoring to syncope, repeated shocks, or haemodynamic collapse in a pacing-dependent patient.

Managing lead fractures in cardiovascular implantable electronic devices: detection and extraction requires more than reacting to a single abnormal impedance value. Clinicians must combine stored electrograms, trends in lead measurements, symptoms, radiographic findings, device dependency, infection status, and the age and type of the lead. An apparent fracture may also represent a header problem, connector issue, insulation breach, or a sensing artefact.

Australia’s geography makes early recognition especially important. A patient living in regional Queensland, Western Australia, or the Northern Territory may be several hours from an electrophysiology service, while a person in Sydney or Melbourne may have rapid access to a tertiary centre. Device clinics, general practitioners, ambulance services, and emergency departments need a shared escalation pathway that remains practical across metropolitan and rural settings.

The safest approach is structured: identify electrical evidence, protect the patient from immediate device-related harm, establish whether the lead can be managed conservatively, and refer promptly when extraction or revision is indicated. Decisions should be individualised, documented clearly, and made with an experienced electrophysiology and cardiac surgery team when procedural risk is significant.

Recognising electrical and clinical warning signs

A lead fracture often produces abrupt or progressive changes in impedance, although the direction varies with the location and nature of the damage. A conductor disruption commonly causes a sudden rise in impedance, while intermittent contact or a header-related problem can produce fluctuating measurements. An insulation defect may cause low impedance and abnormal current drain. These findings become more persuasive when they coincide with nonphysiological short intervals, high-frequency noise, or abrupt changes in sensing amplitude.

Stored electrograms are essential. Lead noise may appear as rapid, irregular signals that do not correspond to surface electrocardiography or the patient’s activity. In an ICD, the device may interpret this noise as ventricular fibrillation and deliver inappropriate therapy. In a pacemaker, oversensing can inhibit pacing, which is particularly hazardous when intrinsic rhythm is absent or unreliable. A patient reporting a “buzzing”, skipped beat, dizziness, blackout, or unexpected shock deserves urgent device interrogation.

Remote monitoring can identify a developing problem before symptoms occur. A single alert should prompt review of the trend, previous episodes, programmed detection criteria, and the lead’s clinical role. Clinicians should also examine whether the abnormality occurs during arm movement, pocket pressure, coughing, or muscle contraction. A chest radiograph with appropriate views can show conductor discontinuity, gross displacement, clavicular crush, or a change in lead contour, but a normal film does not exclude an intermittent fracture. Clear terminology helps when different teams communicate; even general online language resources, such as casino terminology, should never be confused with device-specific clinical definitions.

Protecting patients after suspected failure

The first question is whether the patient is pacing-dependent or at immediate risk from ventricular arrhythmia. Symptoms such as syncope, presyncope, chest pain, palpitations, or repeated ICD shocks require urgent assessment rather than routine outpatient review. Continuous monitoring, intravenous access, and access to external pacing and defibrillation should be arranged when clinically appropriate.

For an ICD with suspected lead noise, tachyarrhythmia therapies may need temporary inactivation under specialist direction, using the device programmer or a magnet according to the manufacturer’s instructions and local protocol. External defibrillation equipment must be immediately available because disabling detection does not remove the patient’s underlying risk of ventricular tachycardia or fibrillation. A magnet can behave differently in pacemakers and ICDs, so staff should confirm the response rather than relying on assumption.

When pacing support is compromised, programming may provide a short-term bridge. Options include changing sensitivity, adjusting detection parameters, selecting another pacing configuration, or using asynchronous pacing in carefully monitored circumstances. These interventions can reduce harm from oversensing but may fail when the conductor is completely open. Temporary transvenous pacing, external pacing, or urgent lead revision may be needed for a dependent patient.

Australian services should plan for transfer early. A person presenting to a district hospital near Dubbo, Geraldton, or Cairns may need retrieval to a centre with extraction capability. Advice from the implanting hospital or a tertiary device service can guide immediate programming while transport is arranged. Patients should receive practical instructions: avoid manipulating the pocket, report every shock, carry their device identification, and tell ambulance clinicians whether ICD therapy has been disabled.

Confirming the cause before intervention

Interrogation should document pacing thresholds, sensing amplitudes, impedance trends, battery status, arrhythmia episodes, stored electrograms, and the timing of alerts. Comparing current measurements with the patient’s historical baseline is often more informative than applying a single universal threshold. A lead that has slowly deteriorated over months may be clinically important even when its value remains within a laboratory reference range.

The physical examination should assess pocket erosion, redness, warmth, tenderness, swelling, venous obstruction, and signs of systemic infection. Lead failure and infection can coexist, and fever or positive blood cultures changes the entire management pathway. Blood cultures, inflammatory markers, echocardiography, and imaging should be selected according to the clinical presentation. Transoesophageal echocardiography is particularly relevant when endocarditis or lead vegetation is suspected.

Provocative testing can reproduce intermittent noise, but it should be performed cautiously and interpreted alongside the stored electrogram. Arm movement, isometric pectoral contraction, and gentle pocket manipulation may help localise a problem near the clavicle, subclavian passage, connector, or pocket. Fluoroscopy can clarify lead position and mechanical deformation. Computed tomography may assist in complex anatomy, venous occlusion, or suspected fracture, although metal artefact and the need for urgent treatment must be considered.

The original implant record matters. Clinicians should identify the manufacturer, model, implant date, lead type, abandoned leads, venous access route, and prior revisions. Some lead families have specific advisories or known failure modes. The patient’s indication also affects urgency: a primary-prevention ICD patient with stable intrinsic rhythm may have a different short-term pathway from someone with secondary-prevention ICD therapy or complete atrioventricular block.

Choosing revision, abandonment, or extraction

Lead revision may involve placing a new lead and capping the failed one, extracting the damaged lead and replacing it, or using an alternative route when venous access is limited. Abandoning a lead can reduce immediate procedural exposure, particularly when the lead is old, extraction risk is high, or infection is absent. It may, however, increase lead burden, obstruct future venous access, complicate magnetic resonance imaging decisions, and make later extraction more difficult.

Extraction becomes strongly favoured when the system is infected, when the lead causes vascular or cardiac complications, or when lead burden and access limitations make abandonment unsafe. A fractured lead alone does not automatically require removal. The balance depends on dwell time, patient age, lead construction, number of existing leads, venous anatomy, pacing dependence, future access needs, and the operator’s extraction experience.

The procedure should be performed in a high-volume service with appropriate imaging, anaesthesia, cardiothoracic surgical support, blood products, and a plan for emergency repair. Lead extraction may use locking stylets, mechanical sheaths, powered sheaths, femoral tools, or a combination of techniques. Adhesion severity often increases with time, and leads implanted for many years can be firmly attached along the subclavian vein, innominate vein, superior vena cava, or endocardial surface.

Before extraction, the team should discuss major risks, including vascular tear, cardiac perforation, tamponade, haemothorax, stroke, death, and the need for urgent sternotomy or thoracotomy. Venography may define obstruction and help plan reimplantation. Where infection is present, complete system removal and targeted antimicrobial therapy are generally required, followed by reassessment of the timing and route of reimplantation.

Building a safer follow-up pathway

After lead revision or extraction, follow-up should verify capture, sensing, impedance, wound healing, battery longevity, and the effectiveness of remote monitoring. The patient should know which symptoms require immediate presentation, including syncope, recurrent shocks, fever, wound discharge, or new swelling of the arm or neck. Device identification records should be updated after every procedure.

Lead management also intersects with arrhythmia risk. A patient with arrhythmogenic right ventricular cardiomyopathy, for example, may need a broader assessment of ventricular arrhythmia risk alongside the mechanical device problem; relevant risk stratification research can inform the clinical discussion. Fixing a lead does not remove the underlying indication for an ICD, nor does a normal interrogation eliminate the need to review disease progression.

Multidisciplinary communication is particularly valuable in Australia’s mixed public and private health system. The device clinic, electrophysiologist, cardiac surgeon, emergency team, GP, and retrieval service should have access to the same procedural history. For Aboriginal and Torres Strait Islander patients and people travelling from remote communities, planning should account for transport, family support, follow-up distance, communication preferences, and the practical cost of repeated metropolitan visits.

Quality improvement depends on reviewing every suspected failure. Clinics can audit alert response times, inappropriate shock episodes, emergency transfers, extraction outcomes, and missed follow-up. Manufacturer advisories, Therapeutic Goods Administration safety communications, and local hospital protocols should be incorporated into device surveillance. A calm, standardised pathway helps clinicians distinguish a manageable lead alert from a time-critical threat.

Use structured interrogation, careful clinical assessment, and early specialist referral whenever lead fracture is suspected. Device clinics and hospital teams should document the electrical findings, protect pacing and defibrillation safety, and involve an experienced extraction service before the situation becomes an emergency. Clinicians can deepen their practice through the Journal of Arrhythmia’s peer-reviewed research, clinical reviews, and educational resources, while patients should be directed to prompt medical care for syncope, repeated shocks, or any new device alarm.